OTO-313 in Subjects With Unilateral Subjective Tinnitus

NCT ID: NCT04829214

Last Updated: 2023-01-06

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

153 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-03-22

Study Completion Date

2022-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the efficacy of OTO-313 in subjects with unilateral tinnitus and to determine the safety and tolerability of OTO-313 in subjects with unilateral tinnitus.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Subjective Tinnitus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized, double-blind, placebo-controlled, multicenter
Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

OTO-313

Group Type EXPERIMENTAL

OTO-313

Intervention Type DRUG

Single intratympanic injection

Placebo

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

Single intratympanic injection

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

OTO-313

Single intratympanic injection

Intervention Type DRUG

Placebo

Single intratympanic injection

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject has early-onset subjective unilateral tinnitus that is persistent (consistently aware of their tinnitus throughout much of the waking day).
* Subject is able to use the diary to complete their daily tinnitus ratings.
* Subject's tinnitus is likely of cochlear origin, e.g., associated with sensorineural hearing loss; acute hearing loss from noise trauma, barotrauma, or traumatic cochlear injury (acute acoustic trauma, blast trauma, middle ear surgery, inner ear barotrauma); age related hearing loss; resolved otitis media; ototoxic drug exposure.
* Subject is willing to comply with the protocol and attend all study visits.

Exclusion Criteria

* Subject has pulsatile tinnitus, temporomandibular joint disease (TMJ) associated with tinnitus perception, tinnitus resulting from traumatic head or neck injury, or tinnitus resulting from a tumor or stroke.
* Subject is pregnant, lactating, or undergoing fertility treatment.
* Subject has other clinically significant illness, medical condition or medical history at Screening or Baseline that, in the Investigator's opinion, would likely reduce the safety of study participation or compliance with study procedures.
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Otonomy, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Central California Clinical Research

Fresno, California, United States

Site Status

Breathe Clear Institute

Torrance, California, United States

Site Status

University of Colorado, Department of Otolaryngology

Aurora, Colorado, United States

Site Status

Colorado ENT & Allergy

Colorado Springs, Colorado, United States

Site Status

ENT and Allergy Associates of FL

Boynton Beach, Florida, United States

Site Status

ENT and Allergy Associates of Florida, LLC

Delray Beach, Florida, United States

Site Status

Research Centers of America

Hollywood, Florida, United States

Site Status

ENT and Allergy Associates of Florida, LLC

Plantation, Florida, United States

Site Status

ENT and Allergy Associates of Florida, LLC

Port Saint Lucie, Florida, United States

Site Status

Ear Research Foundation

Sarasota, Florida, United States

Site Status

Rush University Medical Center

Chicago, Illinois, United States

Site Status

ChicagoENT

Chicago, Illinois, United States

Site Status

Kentuckian Ear, Nose & Throat

Louisville, Kentucky, United States

Site Status

Advanced ENT and Allergy, PLLC

Louisville, Kentucky, United States

Site Status

Tandem Clinical Research

Marrero, Louisiana, United States

Site Status

Center for Specialized Medicine, Department of Otolaryngology-Head and Neck Surgery

St Louis, Missouri, United States

Site Status

Dartmouth-Hitchcock Medical Center/Mary Hitchcock Memorial Hospital

Lebanon, New Hampshire, United States

Site Status

Dent Neurosciences Research Center

Amherst, New York, United States

Site Status

Charlotte Eye Ear Nose & Throat Associates, P.A.

Matthews, North Carolina, United States

Site Status

Piedmont Ear, Nose & Throat Associates, PA

Winston-Salem, North Carolina, United States

Site Status

UC Health Otolaryngology-Head and Neck Surgery

Cincinnati, Ohio, United States

Site Status

Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina

Charleston, South Carolina, United States

Site Status

Carolina Ear, Nose & Throat Clinic/CENTRI Inc.

Orangeburg, South Carolina, United States

Site Status

Spartanburg/Greer ENT & Allergy

Spartanburg, South Carolina, United States

Site Status

Vanderbilt University Medical Center

Nashville, Tennessee, United States

Site Status

Fort Worth ENT

Fort Worth, Texas, United States

Site Status

ENT Associates of Texas

McKinney, Texas, United States

Site Status

Alamo ENT Associates

San Antonio, Texas, United States

Site Status

Chrysalis Clinical Research

St. George, Utah, United States

Site Status

Eastern Virginia Medical School Department of Otolatyngology

Norfolk, Virginia, United States

Site Status

Advanced Otolaryngology, P.C. DBA Richmond ENT

Richmond, Virginia, United States

Site Status

HNO Praxis - Marianne Grohe

Cologne, , Germany

Site Status

Universitätsklinikum Carl Gustav Carus Dresden

Dresden, , Germany

Site Status

HNO - Praxis Göttingen

Göttingen, , Germany

Site Status

HNO Praxis am Necker

Heidelberg, , Germany

Site Status

HNO-Gemeinschaftspraxis

Heidelberg, , Germany

Site Status

Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital

Jena, , Germany

Site Status

Universitätsklinikum Mannheim Klinik für Otorhinolaryngologie, Kopf- und Halschirurgie

Mannheim, , Germany

Site Status

Klinikum der Universitaet Muenchen

München, , Germany

Site Status

Centrum Medyczne Kwiatowa

Bydgoszcz, , Poland

Site Status

Centrum Medyczne ZDROWA

Krakow, , Poland

Site Status

Centrum Medyczne PROMED

Krakow, , Poland

Site Status

MT Medic Specjalistyczna Pralctyka Lekarska Tomasz Stapiński

Krosno, , Poland

Site Status

University Hospitals Birmingham NHS Foundation Trust

Birmingham, , United Kingdom

Site Status

NHS Tayside

Dundee, , United Kingdom

Site Status

University Hospitals of Leicester NHS Trust

Leicester, , United Kingdom

Site Status

Norfolk and Norwich University Hospitals NHS Trust

Norwich, , United Kingdom

Site Status

Sheffield Teaching Hospitals NHS Foundation Trust

Sheffield, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Germany Poland United Kingdom

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

OTO-313-201

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

OTO-104 for Meniere's Disease
NCT01084525 COMPLETED PHASE1